febuprol

Known as: 3-butoxy-1-phenoxy-propanol-(2) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-1987
01219761987

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
The effect of a new potent choleretic drug (Febuprol) on lipid composition and cholesterol nucleation time in gallbladder bile… (More)
Is this relevant?
1987
1987
10 patients with right upper quadrant pain were treated with a choleretic agent (Febuprol; 3 X 200 mg t. i. d.) and placebo in a… (More)
Is this relevant?
1983
1983
In a clinical trial, performed according to new criteria of the AMG (Arzneimittelgesetz) 1976, a new choleretic monosubstance 3-n… (More)
Is this relevant?
1978
1978
In previous pharmacological experiments with the choleretic agent Febuprol, healthy subjects showed a significant increase in… (More)
Is this relevant?
1977
1977
The spasmolytic activity of 3-butoxy-1-phenoxy-propanol-(2) (febuprol) on the biliary tract is demonstrated in two different… (More)
Is this relevant?
1976
1976
The choleretic effect of 3-butoxy-1-phenoxypropanol-(2), Febuprol (INN), was examined in healthy volunteer subjects. In a dose… (More)
Is this relevant?
1976
1976
The pharmacokinetic behaviour as well as metabolization of 3-butoxy - 1 - phenoxy-propanol-(2) (febuprol) in rats and mice were… (More)
Is this relevant?